FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain – Partnership for Safe Medicines
FDA continues to investigate counterfeit Ozempic (semaglutide) injection 1 milligram (mg) in the legitimate U.S. drug supply chain and has seized thousands of units of the product. FDA is aware of five adverse events from this lot.
FDA warns of fake Ozempic in US drug supply chain
US FDA warns about counterfeit versions of Novo's diabetes drug Ozempic
Counterfeit Ozempic found in US drug supply, FDA warns - ABC News
FDA warns of fake Ozempic in US drug supply chain
Counterfeit Ozempic found in US drug supply, FDA warns - ABC News
FDA warns of fake Ozempic in US drug supply chain
US FDA warns about counterfeit versions of Novo's diabetes drug Ozempic
FDA warns of fake Ozempic in US drug supply chain
FDA warns consumers of counterfeit versions of weight loss drug Ozempic
FDA warns of fake Ozempic in US drug supply chain
FDA warns of fake Ozempic in US drug supply chain
November 13, 2023: FDA reporting system shows American injuries from fake Ozempic – Partnership for Safe Medicines
